Company intelligence / Profile preview

OrthAlign

Aliso Viejo, California, United Statesorthalign.com ↗

Ownership: Private
Employees: ~120
Development stage: Commercial

Overview

OrthAlign’s handheld navigation devices are commercially available and have been used in thousands of joint replacement procedures. The company’s technology has demonstrated accuracy in component positioning for total and partial knee as well as total hip replacements. In 2023, the company reported over $50 million in global revenue, reflecting strong commercial adoption

Therapeutic areas: Rheumatology
Modalities: Device
Industry: Surgical Medical Devices

Drug pipeline

2 assets

Lantern Hip

Commercial

Indications: Total hip arthroplasty

1 more asset in the full pipeline.

Request access →

Partnerships

Collaborations with leading orthopedic surgeons and hospitals such as Hospital for Special Surgery

Beyond the preview

Go deeper on OrthAlign.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OrthAlign.

Explore the full profile